Kanazu, M., Mori, M., Kimura, M., Nishino, K., Shiroyama, T., Nagatomo, I., . . . Imamura, F. (2020). Effectiveness of EGFR tyrosine kinase inhibitors in advanced non‐small cell lung cancer patients with uncommon EGFR mutations: A multicenter observational study. Thorac Cancer.
Stile di citazione ChicagoKanazu, Masaki, et al. "Effectiveness of EGFR Tyrosine Kinase Inhibitors in Advanced Non‐small Cell Lung Cancer Patients With Uncommon EGFR Mutations: A Multicenter Observational Study." Thorac Cancer 2020.
Citazione MLAKanazu, Masaki, et al. "Effectiveness of EGFR Tyrosine Kinase Inhibitors in Advanced Non‐small Cell Lung Cancer Patients With Uncommon EGFR Mutations: A Multicenter Observational Study." Thorac Cancer 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.